Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Acute Zika Virus Infection”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Early research (Phase 1)WithdrawnNCT03776695
What this trial is testing

Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients

Who this might be right for
Treatment of Acute Zika Virus Infection
Tychan Pte Ltd.
Early research (Phase 1)Study completedNCT03443830
What this trial is testing

Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans

Who this might be right for
Treatment of Acute Zika Virus Infection
Tychan Pte Ltd. 24